Udaipur Kiran扩大生产, 以提升全球负担得起的药品供应。 Udaipur Kiran expands production to boost affordable drug supply globally.

印度制药部门最近的一项发展涉及Udaipur Kiran,这是一个非专利药品制造商,它扩大了生产能力,以满足国内和国际对负担得起的药品日益增长的需求。 A recent development in India's pharmaceutical sector involves Udaipur Kiran, a generic drug manufacturer, which has expanded its production capacity to meet growing domestic and international demand for affordable medications. 该公司正在投资于新的设施,以提高制造效率,确保遵守全球监管标准。 The company is investing in new facilities to enhance manufacturing efficiency and ensure compliance with global regulatory standards. 这一举动凸显了印度作为全世界非专利药物主要供应国的持续作用。 This move underscores India's continued role as a key supplier of generic drugs worldwide.